Assisted Reproductive Technology Market Analysis By Technology (In-Vitro Fertilization, Artificial Insemination, Surrogacy), By Procedure (Frozen Donor, Frozen Non Donor, Fresh Donor, Fresh Non Donor, Embryo Banking), By Application (Fertility Clinics, Hospitals, Others), By Region &Segment Forecast, 2017 – 2025

  • Product Code:
    RP-ID-10222565
  • Published Date:
    17 Jul 2021
  • Region:
    Global
  • Pages:
    100
  • Category:
    ICT & Telecom
  • Publisher:
    Pub-ID-42

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

ccs

Market Overview:

"In this report, the Global Assisted Reproductive Technology market was valued at USD 21.9 Billion in 2016, and is projected to reach USD 36.7 billion by 2025, growing at a CAGR of 6% over the forecast period.
"Assisted Reproductive Technology Market ", published by Xpodence Research, provides extensive insight and analysis of the Assisted Reproductive Technology Market over the next eight years (2015-2025) and acts as a vital point of reference for operators or suppliers.
Increase in the number of smokers is also anticipated to increase the patient base. Introduction of enhanced technologies for upgrading the outcomes are also expected to increase the market growth over the forecast period. For instance, in August 2015, a treatment method developed by Ovascience’s named as AUGMENT was reported to rejuvenate the eggs of aging women’s and benefit the poor quality eggs.
According to the WHO, the rate of fertility per woman has reduced from five in 1960 to 2.5 in 2012. The declining rates of fertility and increasing stress levels are causing physiological problems which have induced a demand for ART procedures, hence, escalating the market growth. Furthermore, encouraging government and various private organization’s policies for the application of technology is also aiding to the market growth over the forecast period.

The report includes -
Segmentation: Based on technology segment, the report segregates the segment and delivers the revenue, growth rate, and market share, of each type,
• In-vitro Fertilization
• Artificial Insemination
• Surrogacy
• Others
On the basis on the procedure, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
• Frozen Donor
• Frozen Non Donor
• Fresh Donor
• Fresh Non Donor
• Embryo Banking
On the basis of end-user, the market has been segmented further, and displays growth rate and market share over the forecast period;
• Fertility Clinics
• Hospitals
• Others
Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of assisted reproductive technology for these regions, from 2015 to 2025 (forecast)
• North America: U.S., Rest of North America
• Europe: Germany, France, UK, rest of Europe
• Asia Pacific: China, Japan, India and Rest of Asia Pacific
• Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
• Latin America: Brazil and Rest of Latin America
Key players: Overview of market leaders in assisted reproductive technology market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including Esco Micro Pte. Ltd. (Esco Group), Hamilton Thorne, Inc, CooperSurgical, Laboratoire CCD, Irvine Scientific, Vitrolife AB, Merck KGaA, Nidacon International AB, Nikon Corporation and IncPlaner PLC.centrated Solar Power Market ", published by Xpodence Research, provides extensive insight and analysis of the Concentrated Solar Power Market over the next eight years (2015-2025) and acts as a vital point of reference for operators or suppliers.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. RESEARCH METHODOLOGY
2.1. Market Definition
2.2. Market Scope
2.3. Data Sources
3. MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. INDUSTRY OVERVIEW
4.1. Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.3. Key Trends
5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TECHNOLOGY TYPE (2017-2025)
5.1. Global Assisted Reproductive Technology Market, by In-Vitro Fertilization
5.1.1. Global Assisted Reproductive Technology Market, by Intra-Cytoplasmic Sperm Injection (ICSI)
5.1.2. Global Assisted Reproductive Technology Market, by Preimplantation Genetic Diagnosis (PGD)
5.2. Global Assisted Reproductive Technology Market, by Artificial Insemination
5.2.1. Global Assisted Reproductive Technology Market, by Intrauterine Insemination (IUI)
5.2.2. Global Assisted Reproductive Technology Market, by Intracervical Insemination (ICI)
5.3. Global Assisted Reproductive Technology Market, by Surrogacy
5.4. Global Assisted Reproductive Technology Market, by Others
6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PROCEDURES. (2017-2025)
6.1. Global Assisted Reproductive Technology Market, by Frozen Donor
6.2. Global Assisted Reproductive Technology Market, by Frozen Non Donor
6.3. Global Assisted Reproductive Technology Market, by Fresh Donor
6.4. Global Assisted Reproductive Technology Market, by Fresh Non Donor
6.5. Global Assisted Reproductive Technology Market, by Embryo Banking
7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER. (2017-2025)
7.1. Global Assisted Reproductive Technology Market, by Fertility Clinics
7.2. Global Assisted Reproductive Technology Market, by Hospitals
7.3. Global Assisted Reproductive Technology Market, by Others
8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION (2017-2025)
8.1. North America Assisted Reproductive Technology Market
8.1.1. North America Assisted Reproductive Technology Market by Technology
8.1.2. North America Assisted Reproductive Technology Market, by Procedure
8.1.3. North America Assisted Reproductive Technology Market, by End-User
8.1.4. North America Assisted Reproductive Technology Market, by Country
8.1.4.1. U.S. Assisted Reproductive Technology Market
8.1.4.2. Rest of North America Assisted Reproductive Technology Market
8.2. Europe Assisted Reproductive Technology Market
8.2.1. Europe Assisted Reproductive Technology Market by Technology
8.2.2. Europe Assisted Reproductive Technology Market, by Procedure
8.2.3. Europe Assisted Reproductive Technology Market, by End-User
8.2.4. Europe Assisted Reproductive Technology Market, by Country
8.2.4.1. France Assisted Reproductive Technology Market
8.2.4.2. Germany Assisted Reproductive Technology Market
8.2.4.3. U.K Assisted Reproductive Technology Market
8.2.4.4. Rest of Europe v Market
8.3. Asia Pacific Assisted Reproductive Technology Market
8.3.1. Asia Pacific Assisted Reproductive Technology Market by Technology
8.3.2. Asia Pacific Assisted Reproductive Technology Market, by Procedure
8.3.3. Asia Pacific Assisted Reproductive Technology Market, by End-User
8.3.4. Asia-Pacific Assisted Reproductive Technology Market, by Country
8.3.4.1. China Assisted Reproductive Technology Market
8.3.4.2. Japan Assisted Reproductive Technology Market
8.3.4.3. India Assisted Reproductive Technology Market
8.3.4.4. Rest of Asia Pacific Assisted Reproductive Technology Market
8.4. Middle East & Africa Assisted Reproductive Technology Market
8.4.1. Middle East & Africa Assisted Reproductive Technology Market by Technology
8.4.2. Middle East & Africa Assisted Reproductive Technology Market, by Procedure
8.4.3. Middle East & Africa Assisted Reproductive Technology Market, by End-User
8.4.4. Middle East & Africa Assisted Reproductive Technology Market, by Country
8.4.4.1. GCC Assisted Reproductive Technology Market
8.4.4.2. North Africa Assisted Reproductive Technology Market
8.4.4.3. South Africa Assisted Reproductive Technology Market
8.4.4.4. Rest of Middle East & Africa Assisted Reproductive Technology Market
8.5. Latin America Assisted Reproductive Technology Market
8.5.1. Latin America Assisted Reproductive Technology Market by Technology
8.5.2. Latin America Assisted Reproductive Technology Market, by Procedure
8.5.3. Latin America Assisted Reproductive Technology Market, by End-User
8.5.4. Latin America Assisted Reproductive Technology Market by Country
8.5.4.1. Brazil Assisted Reproductive Technology Market
8.5.4.2. Rest of Latin America Assisted Reproductive Technology Market
9. MARKET COMPETITION ANALYSIS
9.1. Market Share/Positioning Analysis
9.2. Key Innovators
9.3. Company Profiles
9.3.1. Merck KGaA
9.3.1.1. Overview
9.3.1.2. Type/Service Offerings
9.3.1.3. Strategy
9.3.1.4. Key Developments
9.3.2. CooperSurgical, Inc.
9.3.2.1. Overview
9.3.2.2. Type/Service Offerings
9.3.2.3. Strategy
9.3.2.4. Key Developments
9.3.3. Irvine Scientific
9.3.3.1. Overview
9.3.3.2. Type/Service Offerings
9.3.3.3. Strategy
9.3.3.4. Key Developments
9.3.4. Vitrolife AB
9.3.4.1. Overview
9.3.4.2. Type/Service Offerings
9.3.4.3. Strategy
9.3.4.4. Key Developments
9.3.5. Hamilton Thorne, Inc.
9.3.5.1. Overview
9.3.5.2. Type/Service Offerings
9.3.5.3. Strategy
9.3.5.4. Key Developments
9.3.6. Nidacon International AB
9.3.6.1. Overview
9.3.6.2. Type/Service Offerings
9.3.6.3. Strategy
9.3.6.4. Key Developments
9.3.7. Laboratoire CCD
9.3.7.1. Overview
9.3.7.2. Type/Service Offerings
9.3.7.3. Strategy
9.3.7.4. Key Developments
9.3.8. Planer PLC
9.3.8.1. Overview
9.3.8.2. Type/Service Offerings
9.3.8.3. Strategy
9.3.8.4. Key Developments
9.3.9. Esco Micro Pte. Ltd. (Esco Group)
9.3.9.1. Overview
9.3.9.2. Type/Service Offerings
9.3.9.3. Strategy
9.3.9.4. Key Developments
9.3.10. Nikon Corporation
9.3.10.1. Overview
9.3.10.2. Type/Service Offerings
9.3.10.3. Strategy
9.3.10.4. Key Developments
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
0
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports